| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef416fe4f66ebb1021cecfb0ba5ae45d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f17a53ce656a120fe517d3bd87669c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b135c1328b491ebfbdef56dee0ac730 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6087 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 |
| filingDate |
2011-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfedd29859ca4b59266fdc66b8b3ac68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6672188c906375d2da62d631ea58fd51 |
| publicationDate |
2013-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013164325-A1 |
| titleOfInvention |
Ceramide-like glycolipid-associated bacterial vaccines and uses thereof |
| abstract |
The invention is directed compositions and methods related to bacterial cells that are physically associated with ceramide-like glycolipids for use as antigen carriers for heterologous antigens. The invention further relates to methods of incorporating ceramide-like glycolipid to bacterial cell walls. The compositions and methods of the present invention are useful for the prevention and treatment of diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114341175-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010183549-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9809654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10640765-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9139809-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10662422-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9603922-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9371352-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111950-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10577427-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10550199-B2 |
| priorityDate |
2010-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |